Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Assoc Physicians India. 2002 Oct;50:1316-7.

Indirect hyperbilirubinemia with indinavir.

Author information

  • 1Department of Medicine, TN Medical College and BYL Nair Charitable Hospital, Mumbai.

Abstract

Indinavir is a protease inhibitor used in the treatment of HIV infected individuals and as post-exposure prophylaxis. Indinavir is associated with various adverse effects including gastrointestinal, a lipodystrophy syndrome and nephrolithiasis. We describe indirect hyperbilirubinemia as an adverse effect of indinavir in a person on post-exposure prophylaxis (PEP).

PMID:
12568221
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk